Leading provider of high quality home healthcare services, LloydsPharmacy Clinical Homecare (LPCH) has appointed Gabrielle Silver as its new general manager. Gabrielle will lead the LPCH operations and growth strategy and will join the business on Monday 20th November.
Gabrielle commented: “I’m delighted to be joining such a progressive business that really has patient care as its core focus. I am looking forward to exploring how we can further develop this best in class homecare business and more effectively partner with healthcare providers to improve patient care and outcomes.”
She joins from Brunswick Group, a strategic advisory firm specialising in critical issue and reputation management, where she co-led the global healthcare practice and advised senior level leadership at multinational companies across the consumer health, pharmaceuticals and medical technology sectors.
Gabrielle has a background in healthcare and life sciences and previously led the GE Healthcare Global Strategic Marketing Organisation with a focus on technology and software solutions for the Operating Room and for Neurology. She also spent nine years in global roles within the pharmaceutical sector, including Eisai and Bristol Myers Squibb, where she was responsible for the development, launch and commercialisation of innovative therapies within neuroscience, psychiatry and pain management.
As a qualified doctor, Gabrielle is well versed with the UK public sector and serves as an associate non-executive director for the Royal National Orthopaedic Hospital (RNOH) NHS Trust. She also serves as a director for a US pharmaceutical business focused on therapies for addiction. She is passionate about prioritising the diversity agenda within business and previously led the GE Commercial Women’s Network in Europe.
Ruth Poole, Celesio UK speciality director commented: “I’m really excited that Gabrielle is bringing her dedication and experience to our team. Her industry knowledge and healthcare background make her a perfect fit for the team. Gabrielle will play a key role in delivering the UK speciality growth strategy, helping us to support the NHS to deliver better care to patients and improve outcomes.
This appointment underlines Celesio’s commitment to delivering the highest quality healthcare services to patients in the UK.”
For any media enquiries please contact the Celesio UK PR team:
Claire Salmons (firstname.lastname@example.org) 024 7662 5530
Joe Scholes (email@example.com) 024 7643 2055
Notes to editor
LloydsPharmacy Clinical Homecare is a leading provider of high quality home healthcare services supporting over 64,000 patients across the UK. It works in partnership with the NHS, pharmaceutical industry and private medical insurers to support patients with a range of conditions. LloydsPharmacy Clinical Homecare employs approximately 1000 people who work across the UK.
Celesio UK is a leading provider of integrated healthcare services to the NHS specialising in medicines, pharmaceutical care and primary care patient services.
With almost 25,000 employees, more than 1,750 community pharmacies, a UK-wide logistics network and dispensing in excess of 150 million items a year, Celesio UK works in partnership with the NHS, community pharmacies and medicines manufacturers to help UK citizens live longer, healthier and more positive lives. Celesio UK provides customers, the NHS and patients with high levels of service, value, efficiency and innovation.
Celesio UK is part of McKesson Europe and comprises LloydsPharmacy, AAH Pharmaceuticals, LloydsPharmacy Clinical Homecare, Masta, Online Doctor and Betterlife.
McKesson Europe is a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sector. The proactive and preventive approach ensures that patients receive the products and support that they require for optimum care.
With strong brands and about 39,000 employees, the group is active in 13 European countries (thereof with own operations in ten countries; additionally McKesson Europe manages operations in three countries and participates in one country in a joint venture). Every day, the company serves over 2 million customers – at more than 2,100 pharmacies of its own, at about 300 managed pharmacies and at over 5,700 participants in the brand partnership schemes. With 110 own and seven managed wholesale branches in Europe, McKesson Europe supplies more than 55,000 pharmacies and hospitals every day with up to 130,000 pharmaceutical products.
McKesson Corporation, San Francisco, USA, is the majority shareholder in McKesson Europe. McKesson is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology.